We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
NMVA
1
New Mountain Vantage Advisers
New York
$36.6M
PCM
2
Puissance Capital Management
New York
$20.1M
VMI
3
VHCP Management II
New York
$10M
BC
4
Boxer Capital
California
$4.49M
Renaissance Technologies
5
Renaissance Technologies
New York
$2.81M +$291K +8,420 +12%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.42M +$36.7K +1,060 +2%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$1.57M
JP Morgan Chase
8
JP Morgan Chase
New York
$574K +$496K +14,334 +961%
EI
9
EAM Investors
California
$562K
Geode Capital Management
10
Geode Capital Management
Massachusetts
$498K +$141K +4,087 +42%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$423K -$2.8K -81 -0.7%
TI
12
Telemetry Investments
New York
$351K -$125K -3,600 -27%
BCM
13
Bridgeway Capital Management
Texas
$298K +$231K +6,667 +435%
DS
14
DRW Securities
Illinois
$254K +$80.7K +2,333 +50%
Northern Trust
15
Northern Trust
Illinois
$156K
BlackRock
16
BlackRock
New York
$155K -$30.9K -893 -17%
LPL Financial
17
LPL Financial
California
$152K
Creative Planning
18
Creative Planning
Kansas
$110K +$16.2K +469 +18%
VF
19
Virtu Financial
New York
$49K +$46.6K +1,347 New
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$46K
State Street
21
State Street
Massachusetts
$33K
CIBC Private Wealth Group
22
CIBC Private Wealth Group
Georgia
$30K
Millennium Management
23
Millennium Management
New York
$27K -$14K -406 -36%
GC
24
Grace Capital
Massachusetts
$11K +$10.6K +306 New
Morgan Stanley
25
Morgan Stanley
New York
$9K +$7.13K +206 +624%